Your browser doesn't support javascript.
loading
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Martina Milighetti; Yanchun Peng; Cedric C.S. Tan; Michal Mark; Gayathri Nageswaran; Suzanne Byrne; Tahel Ronel; Thomas Peacock; Andreas Mayer; Aneesh Chandran; Joshua Rosenheim; Matthew Wheelan; Xuan Yao; Guihai Liu; Suet Ling Felce; Tao Dong; Alexander J Mentzer; Julian Charles Knight; Francois Balloux; Erez Greenstein; Shlomit Reich-Zeliger; Corinna Pade; Joseph M Gibbons; Amanda Semper; Tim Brooks; Ashley Otter; Daniel M Altmann; Rosemary J Boyton; Mala K Maini; Aine McKnight; Charlotte Manisty; Thomas A Treibel; James C Moon; - COVIDsortium Investigators; Mahdad Noursadeghi; Benny Chain.
Afiliación
  • Martina Milighetti; University College London
  • Yanchun Peng; University of Oxford
  • Cedric C.S. Tan; University College London
  • Michal Mark; Weizmann Institute of Science
  • Gayathri Nageswaran; University College London
  • Suzanne Byrne; University College London
  • Tahel Ronel; University College London
  • Thomas Peacock; University College London
  • Andreas Mayer; University College London
  • Aneesh Chandran; University College London
  • Joshua Rosenheim; University College London
  • Matthew Wheelan; University College London
  • Xuan Yao; University of Oxford
  • Guihai Liu; University of Oxford
  • Suet Ling Felce; University of Oxford
  • Tao Dong; University of Oxford
  • Alexander J Mentzer; University of Oxford
  • Julian Charles Knight; University of Oxford
  • Francois Balloux; Imperial College Faculty of Medicine
  • Erez Greenstein; Weizmann Institute of Science
  • Shlomit Reich-Zeliger; Weizmann Institute of Science
  • Corinna Pade; Queen Mary University of London
  • Joseph M Gibbons; Queen Mary University of London
  • Amanda Semper; Queen Mary University of London
  • Tim Brooks; UK Health Security Agency
  • Ashley Otter; UK Health Security Agency
  • Daniel M Altmann; Imperial College London
  • Rosemary J Boyton; Imperial College London
  • Mala K Maini; University College London
  • Aine McKnight; Queen Mary University of London
  • Charlotte Manisty; University College London
  • Thomas A Treibel; University College London
  • James C Moon; University College London
  • - COVIDsortium Investigators; -
  • Mahdad Noursadeghi; University College London
  • Benny Chain; University College London
Preprint en En | PREPRINT-BIORXIV | ID: ppbiorxiv-515436
ABSTRACT
We analyzed the dynamics of the earliest T cell response to SARS-COV-2. A wave of TCRs strongly but transiently expand during infection, frequently peaking the same week as the first positive PCR test. These expanding TCR CDR3s were enriched for sequences functionally annotated as SARS-COV-2 specific. Most epitopes recognized by the expanding TCRs were highly conserved between SARS-COV-2 strains, but not with circulating human coronaviruses. Many expanding CDR3s were also present at high precursor frequency in pre-pandemic TCR repertoires. A similar set of early response TCRs specific for lymphocytic choriomeningitis virus epitopes were also found at high frequency in the pre-infection naive repertoire. High frequency naive precursors may allow the T cell response to respond rapidly during the crucial early phases of acute viral infection. One-Sentence SummaryHigh frequency naive precursors underly the rapid T cell response during the crucial early phases of acute viral infection.
Licencia
cc_by
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2022 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2022 Tipo del documento: Preprint
...